Amjevita Injection
Product Images NDC 55513-482

Product Visual Gallery

This gallery contains 42 technical images submitted to the FDA as part of the official labeling for Amjevita (NDC 55513-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amjevita 01)

The text appears to be a graph showing the administration of a medication (40mg every other week) compared to a placebo over a period of weeks. The label on the x-axis indicates the measurement of time.*

FDA Label Image

Figure 2 (Amjevita 02)

The text is describing a chart or graph showing the ASAS 20 response of a placebo group (consisting of 107 participants) compared to an adalimumab group (consisting of 208 participants) over a period of 24 weeks. The chart/plot shows time on the x-axis (measured in weeks) and the ASAS 20 response on the y-axis. Without access to the visual aids, further interpretation or insight is not feasible.*

FDA Label Image

Image (Amjevita 03)

FDA Label Image

Image (Amjevita 04)

This appears to be a set of instructions or information related to a medical injection device. It includes details about the expiration date and the color-coding of various components, such as the yellow window and safety guard. It also references removing the yellow cap.*

FDA Label Image

Image (Amjevita 05)

FDA Label Image

Image (Amjevita 06)

FDA Label Image

Image (Amjevita 07)

This text is describing two body parts: the stomach area (abdomen) and the thigh.*

FDA Label Image

Image (Amjevita 08)

FDA Label Image

Image (Amjevita 09)

FDA Label Image

Image (Amjevita 10)

FDA Label Image

Image (Amjevita 11)

FDA Label Image

Image (Amjevita 12)

FDA Label Image

Image (Amjevita 13)

FDA Label Image

Image (Amjevita 14)

FDA Label Image

Image (Amjevita 15)

FDA Label Image

Image (Amjevita 16)

FDA Label Image

Image (Amjevita 17)

FDA Label Image

Image (Amjevita 18)

FDA Label Image

Image (Amjevita 19)

FDA Label Image

Image (Amjevita 20)

FDA Label Image

Image (Amjevita 21)

This appears to be a list of body parts: Stomach area (abdomen) and Thigh. No further context or description is available.*

FDA Label Image

Image (Amjevita 22)

FDA Label Image

Image (Amjevita 23)

FDA Label Image

Image (Amjevita 24)

FDA Label Image

Image (Amjevita 25)

FDA Label Image

Image (Amjevita 26)

FDA Label Image

Image (Amjevita 27)

This text seems to be a list of components of a medication syringe including a plunger rod, finger flange, label with an expiration date, syringe barrel, medicine, and a needle cap.*

FDA Label Image

Image (Amjevita 28)

This appears to be a list of various components typically found in medical syringe equipment, including a used plunger rod, finger flange, label and expiration date, used syringe barrel, used needle, and needle cap. It does not provide any specific information about the condition of these items or their intended use.*

FDA Label Image

Image (Amjevita 29)

FDA Label Image

Image (Amjevita 30)

FDA Label Image

Image (Amjevita 31)

Not available.*

FDA Label Image

Image (Amjevita 32)

FDA Label Image

Image (Amjevita 33)

This is a medical term indicating two parts of the human body. The first one refers to the area of the body located between the chest and the pelvis, commonly known as the "stomach" or "abdomen". This area contains vital organs such as the stomach, liver, intestines, kidneys, and spleen. The second term refers to the upper part of the leg, extending from the hip to the knee, known as the "thigh". It contains several muscles, including the quadriceps and hamstrings, that are essential for movement and mobility.*

FDA Label Image

Image (Amjevita 34)

FDA Label Image

Image (Amjevita 35)

FDA Label Image

Image (Amjevita 36)

FDA Label Image

Image (Amjevita 37)

FDA Label Image

Image (Amjevita 38)

FDA Label Image

Image (Amjevita 39)

FDA Label Image

Principal Display Panel (20 mg Syringe Carton)

This is a medication called Adalimumab-atto, which is an injectable solution for subcutaneous use. It comes in a single-dose prefilled syringe with a storage temperature between 2-8°C (36°F-46°F) and should not be frozen or shaken. It is intended for people who weigh between 18kg to <%0 kg and the package includes additional instructions for storage. However, the text provided is unreliable and contains errors that make the information difficult to read.*

FDA Label Image

Principal Display Panel (40 mg Syringe Carton)

FDA Label Image

Principal Display Panel (40 mg Autoinjector Carton)

This appears to be a description of a medication called "fAMJEVITA" with the active ingredient "adalimumab-atto". It is a sterile solution in a prefilled autoinjector that should be stored refrigerated and protected from light, and should not be shaken or frozen. It is intended for subcutaneous use only and the enclosed medication guide is required for each use. The product is not made with natural rubber latex and should not be re-used. Other text in the description is not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.